PIONEERING THE VEGETABLE ORIGIN PHARMA
Canamedics is in the process of obtaining the relevant licenses to produce EU GMP cannabis dried flowers to be used as active pharmaceutical ingredients (API).
Canamedics EU GACP/GMP production facilities will be located in Barcelona, Spain.
Canamedics will be fully operational by 2021.
As its starting plant materials, Canamedics prides on its catalogue of legal certified origin cannabis strains obtained from verified suppliers.
ACTIVE PHARMACEUTICAL INGREDIENTS
The client will choose the strain and Canamedics will grow and deliver EU GMP cannabis dried flowers to be used as APIs.
R & D
Canamedics is sponsoring pre-clinical trials committed to research into the efficacy and safety of the use of cannabinoids in the treatment of pain and muscle stiffness derived from neurological diseases.
EU GACP/GMP state-of-the-art cannabis cultivation and processing facilities
Taking the fundamentals of control and precision of indoor crops together with Spain's climate advantages and the sustainability offered by high-performance greenhouses, Canamedics is designing a hydroponic phytotron-greenhouse at the highest pharmaceutical standards and EU GACP compliant.
For the treatment and processing of the plant material collected from the phytotron unit, Canamedics its desiging a EU GMP processing center where, among others, the trimming, drying, curing and testing of the cannabis dried flowers will take place in order to obtain APIs.
Batch release is going to be constant and frequent in a small (but scalable) volume to maintain the highest degree of pharmaceutical quality in a highly rotating, easily perishable, plant-based product.
Therefore, Canamedics minimizes the risks of product recall and adapts to the absorption capacities of the markets, as well as to the successful management model in distribution, storage and consumption in the pharmaceutical sector of plant origin.
These are just some of the partners with whom
we pride to be working with
Canamedics Labs, S.L. has been a beneficiary of the European Regional Development Fund whose objective is to improve the competitiveness of SMEs and thanks to which it has launched an International Digital Marketing Plan with the aim of improving its online positioning in foreign markets during 2020. To do this, Canamedics Labs has had the support of the XPANDE DIGITAL Program of the Terrassa Chamber of Commerce.
A way to make Europe